Menu
GeneBe

X-101349693-C-T

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000061.3(BTK):c.*192G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 442,227 control chromosomes in the GnomAD database, including 14,552 homozygotes. There are 35,609 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.32 ( 5892 hom., 10233 hem., cov: 22)
Exomes 𝑓: 0.24 ( 8660 hom. 25376 hem. )

Consequence

BTK
NM_000061.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 0.493
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant X-101349693-C-T is Benign according to our data. Variant chrX-101349693-C-T is described in ClinVar as [Benign]. Clinvar id is 367693.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BTKNM_000061.3 linkuse as main transcriptc.*192G>A 3_prime_UTR_variant 19/19 ENST00000308731.8
BTKNM_001287344.2 linkuse as main transcriptc.*192G>A 3_prime_UTR_variant 19/19
BTKNM_001287345.2 linkuse as main transcriptc.*192G>A 3_prime_UTR_variant 17/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BTKENST00000308731.8 linkuse as main transcriptc.*192G>A 3_prime_UTR_variant 19/191 NM_000061.3 P3Q06187-1

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
35251
AN:
110320
Hom.:
5884
Cov.:
22
AF XY:
0.313
AC XY:
10199
AN XY:
32608
show subpopulations
Gnomad AFR
AF:
0.629
Gnomad AMI
AF:
0.0973
Gnomad AMR
AF:
0.349
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.439
Gnomad SAS
AF:
0.445
Gnomad FIN
AF:
0.154
Gnomad MID
AF:
0.181
Gnomad NFE
AF:
0.156
Gnomad OTH
AF:
0.281
GnomAD4 exome
AF:
0.237
AC:
78600
AN:
331854
Hom.:
8660
Cov.:
4
AF XY:
0.245
AC XY:
25376
AN XY:
103512
show subpopulations
Gnomad4 AFR exome
AF:
0.630
Gnomad4 AMR exome
AF:
0.462
Gnomad4 ASJ exome
AF:
0.146
Gnomad4 EAS exome
AF:
0.473
Gnomad4 SAS exome
AF:
0.460
Gnomad4 FIN exome
AF:
0.155
Gnomad4 NFE exome
AF:
0.158
Gnomad4 OTH exome
AF:
0.242
GnomAD4 genome
AF:
0.320
AC:
35298
AN:
110373
Hom.:
5892
Cov.:
22
AF XY:
0.313
AC XY:
10233
AN XY:
32671
show subpopulations
Gnomad4 AFR
AF:
0.629
Gnomad4 AMR
AF:
0.349
Gnomad4 ASJ
AF:
0.151
Gnomad4 EAS
AF:
0.439
Gnomad4 SAS
AF:
0.444
Gnomad4 FIN
AF:
0.154
Gnomad4 NFE
AF:
0.156
Gnomad4 OTH
AF:
0.285
Alfa
AF:
0.185
Hom.:
9957
Bravo
AF:
0.355

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

X-linked agammaglobulinemia with growth hormone deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
X-linked agammaglobulinemia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
Cadd
Benign
7.0
Dann
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1057403; hg19: chrX-100604681; COSMIC: COSV58119536; COSMIC: COSV58119536; API